Calypso Biotech BV
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Dose Escalation Study to Evaluate an Experimental New Treatment (CALY-002) in Healthy Subjects and Subjects With Celiac Disease and Eosinophilic Esophagitis (NCT04593251) | Calypso Biotech BV | 2020-09-28 |
Track Calypso Biotech BV automatically
Every clearance here is in the API, with alerts when new ones post.